These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26776392)

  • 21. [Treating a psychotic syndrome in 2007].
    Olié JP
    Therapie; 2008; 63(3):165-75. PubMed ID: 18718208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined use of ECT with aripiprazole.
    Lopez-Garcia P; Chiclana C; Gonzalez R
    World J Biol Psychiatry; 2009; 10(4 Pt 3):942-3. PubMed ID: 17853257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensive high-frequency repetitive transcranial magnetic stimulation in schizophrenia: a case study.
    Sverak T; Prikryl R; Mayerova M; Anderkova L
    J ECT; 2014 Dec; 30(4):e51-3. PubMed ID: 25181021
    [No Abstract]   [Full Text] [Related]  

  • 24. Antipsychotic monotherapy and adjuvant psychotropic therapies in schizophrenia patients: effect on time to readmission.
    Valevski A; Gilat Y; Olfson M; Benaroya-Milshtein N; Weizman A
    Int Clin Psychopharmacol; 2012 May; 27(3):159-64. PubMed ID: 22466059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing Negative Symptoms of Schizophrenia: How Far Have We Come?
    Kantrowitz JT
    CNS Drugs; 2017 May; 31(5):373-388. PubMed ID: 28397113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deep transcranial magnetic stimulation add-on for treatment of negative symptoms and cognitive deficits of schizophrenia: a feasibility study.
    Levkovitz Y; Rabany L; Harel EV; Zangen A
    Int J Neuropsychopharmacol; 2011 Aug; 14(7):991-6. PubMed ID: 21524336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seizure activity in combined clozapine and ECT: a retrospective view.
    Cardwell BA; Nakai B
    Convuls Ther; 1995 Jun; 11(2):110-3. PubMed ID: 7552049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or cul-de-sac?
    Buckley PF; Stahl SM
    Acta Psychiatr Scand; 2007 Feb; 115(2):93-100. PubMed ID: 17244172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroleptic-resistant schizophrenia treated with clozapine and ECT.
    Benatov R; Sirota P; Megged S
    Convuls Ther; 1996 Jun; 12(2):117-21. PubMed ID: 8744173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined use of electroconvulsive therapy and antipsychotics in schizophrenia: the Indian evidence. A review and a meta-analysis.
    Painuly N; Chakrabarti S
    J ECT; 2006 Mar; 22(1):59-66. PubMed ID: 16633210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concurrent administration of clozapine and ECT: a successful therapeutic strategy for a patient with treatment-resistant schizophrenia.
    Bhatia SC; Bhatia SK; Gupta S
    J ECT; 1998 Dec; 14(4):280-3. PubMed ID: 9871852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness and clinical predictors of response to combined ECT and antipsychotic therapy in patients with treatment-resistant schizophrenia and dominant negative symptoms.
    Pawełczyk T; Kołodziej-Kowalska E; Pawełczyk A; Rabe-Jabłońska J
    Psychiatry Res; 2014 Dec; 220(1-2):175-80. PubMed ID: 25129562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New therapeutic approaches for treatment-resistant schizophrenia: a look to the future.
    Miyamoto S; Jarskog LF; Fleischhacker WW
    J Psychiatr Res; 2014 Nov; 58():1-6. PubMed ID: 25070124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjunctive treatment of bimodal repetitive transcranial magnetic stimulation (rTMS) in pharmacologically non-responsive patients with schizophrenia: a preliminary study.
    Oh SY; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1938-43. PubMed ID: 21840364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjunctive treatments in schizophrenia: pharmacotherapies and electroconvulsive therapy.
    Johns CA; Thompson JW
    Schizophr Bull; 1995; 21(4):607-19. PubMed ID: 8749888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful use of maintenance rTMS for 8 months in a patient with antipsychotic-refractory auditory hallucinations.
    Thirthalli J; Bharadwaj B; Kulkarni S; Gangadhar BN; Kharawala S; Andrade C
    Schizophr Res; 2008 Mar; 100(1-3):351-2. PubMed ID: 18252271
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacological approaches to treating negative symptoms: a review of clinical trials.
    Arango C; Garibaldi G; Marder SR
    Schizophr Res; 2013 Nov; 150(2-3):346-52. PubMed ID: 23938176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can repetitive transcranial magnetic stimulation be considered effective treatment option for negative symptoms of schizophrenia?
    Prikryl R; Kucerova HP
    J ECT; 2013 Mar; 29(1):67-74. PubMed ID: 23303418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using ECT in schizophrenia: a review from a clinical perspective.
    Zervas IM; Theleritis C; Soldatos CR
    World J Biol Psychiatry; 2012 Feb; 13(2):96-105. PubMed ID: 21486108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Electroconvulsive therapy and schizophrenia].
    Mouchet-Mages S
    Encephale; 2007 Jun; 33 Pt 3():S415-8. PubMed ID: 19101362
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.